Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:53 PM
Ignite Modification Date:
2025-12-24 @ 10:53 PM
NCT ID:
NCT00908869
Eligibility Criteria:
Inclusion Criteria:
* patients aged from 18 and older,
* with metastatic or advanced solid tumor who received all standard treatments,
* who ended their chemotherapy or radiotherapy treatment within 4 weeks (6 weeks for mitocyne)prior entry in the study.
* All patients are included after being given written informed consent.
Exclusion Criteria:
* patients with stable disease,
* history or presence of another cancer,
* contraindication to administer the treatment,
* contraindication to perform MRI,
* pregnancy or breast feeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00908869
Study Brief:
Protocol Section:
NCT00908869